BNP Paribas Exane Cuts Clorox (NYSE:CLX) Price Target to $101.00

Clorox (NYSE:CLX) had its target price cut by BNP Paribas Exane from $103.00 to $101.00 in a research note released on Friday,MarketScreener reports. They currently have an underperform rating on the stock.

Other equities analysts have also recently issued reports about the company. Weiss Ratings reiterated a “hold (c-)” rating on shares of Clorox in a research note on Friday, January 9th. Morgan Stanley cut their price target on shares of Clorox from $137.00 to $125.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 4th. UBS Group decreased their price objective on shares of Clorox from $119.00 to $115.00 and set a “neutral” rating for the company in a report on Wednesday. JPMorgan Chase & Co. cut their target price on shares of Clorox from $120.00 to $114.00 and set a “neutral” rating on the stock in a research note on Friday. Finally, Jefferies Financial Group reiterated a “buy” rating and issued a $152.00 price target on shares of Clorox in a research note on Tuesday, November 4th. One investment analyst has rated the stock with a Buy rating, fourteen have given a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Reduce” and an average target price of $122.19.

Clorox Stock Down 1.2%

CLX opened at $109.95 on Friday. The firm has a market cap of $13.41 billion, a P/E ratio of 17.26, a PEG ratio of 0.54 and a beta of 0.58. The business’s fifty day simple moving average is $103.13 and its 200 day simple moving average is $115.20. Clorox has a 52 week low of $96.66 and a 52 week high of $164.22. The company has a quick ratio of 0.50, a current ratio of 0.76 and a debt-to-equity ratio of 18.01.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Monday, November 3rd. The company reported $0.85 EPS for the quarter, beating analysts’ consensus estimates of $0.78 by $0.07. Clorox had a return on equity of 358.39% and a net margin of 11.68%.The business had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. During the same quarter in the previous year, the business earned $1.86 earnings per share. The business’s revenue for the quarter was down 18.9% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. As a group, equities research analysts anticipate that Clorox will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 28th will be paid a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a yield of 4.5%. The ex-dividend date is Wednesday, January 28th. Clorox’s dividend payout ratio (DPR) is presently 77.86%.

Insider Activity

In other news, Director Pierre R. Breber purchased 4,000 shares of the stock in a transaction dated Friday, November 21st. The stock was acquired at an average price of $104.13 per share, for a total transaction of $416,520.00. Following the completion of the transaction, the director owned 13,000 shares of the company’s stock, valued at approximately $1,353,690. The trade was a 44.44% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.63% of the company’s stock.

Institutional Trading of Clorox

Several hedge funds have recently bought and sold shares of the company. Center for Financial Planning Inc. bought a new position in Clorox in the 3rd quarter worth about $25,000. Vermillion & White Wealth Management Group LLC acquired a new position in shares of Clorox during the third quarter worth approximately $25,000. Total Investment Management Inc. bought a new position in Clorox in the 2nd quarter worth approximately $25,000. American National Bank & Trust grew its holdings in Clorox by 69.5% in the 2nd quarter. American National Bank & Trust now owns 217 shares of the company’s stock worth $26,000 after buying an additional 89 shares in the last quarter. Finally, True Wealth Design LLC increased its position in Clorox by 1,020.0% in the 3rd quarter. True Wealth Design LLC now owns 224 shares of the company’s stock valued at $28,000 after acquiring an additional 204 shares during the period. 78.53% of the stock is currently owned by institutional investors.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.